The worldwide oncology market is expanding as a result of the growing cancer conference 2023 burden globally caused by rising alcohol and cigarette use. In its GLOBOCAN report, the International Agency for Research on Cancer (IARC) estimates that there were roughly 19.3 million new cases of cancer and 10 million cancer-related deaths worldwide in 2020.
Thus, it is anticipated that the rising incidence of cancer would encourage the use of oncology diagnostics and oncology treatments everywhere, thereby fostering the expansion of the worldwide cancer conference 2023 market anticipated that the market would rise as a result of increased government and non-profit to awareness about cancer prevention. For instance, the Global Action Plan for Prevention and Control of Non-Communicable Diseases of the World Health Organization seeks to reduce the number of preventable deaths from diabetes, cancer, cardiovascular disease, and other chronic respiratory illnesses by around 25% by the year 2025.
